Crinetics Pharmaceuticals, Inc. financial data

Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
Location
10222 Barnes Canyon Road, Bldg. #2, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.59K % +34%
Debt-to-equity 13.3 % -8.29%
Return On Equity -36.1 % +36.7%
Return On Assets -31.9 % +36%
Operating Margin 1.38M %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 92.7M shares +69.6%
Common Stock, Shares, Outstanding 80.8M shares +21.2%
Entity Public Float 1B USD 0%
Common Stock, Value, Issued 881K USD
Weighted Average Number of Shares Outstanding, Basic 80.1M shares +41%
Weighted Average Number of Shares Outstanding, Diluted 80.1M shares +41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 219M USD +37%
General and Administrative Expense 88.6M USD +69.5%
Operating Income (Loss) -307M USD -47.8%
Nonoperating Income (Expense) 33.5M USD +269%
Net Income (Loss) Attributable to Parent -278M USD -39.4%
Earnings Per Share, Basic -3.72 USD/shares -2.48%
Earnings Per Share, Diluted -3.72 USD/shares -2.48%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 317M USD +122%
Cash, Cash Equivalents, and Short-term Investments 863M USD +55.5%
Other Assets, Current 1.49M USD -57.8%
Assets, Current 878M USD +52.4%
Property, Plant and Equipment, Net 11.7M USD +19.9%
Operating Lease, Right-of-Use Asset 44.3M USD -7.86%
Other Assets, Noncurrent 2.51M USD +25.6%
Assets 937M USD +46.1%
Accounts Payable, Current 4.94M USD -15.5%
Liabilities, Current 53.6M USD +32.4%
Operating Lease, Liability, Noncurrent 45.1M USD -6.34%
Other Liabilities, Noncurrent 511K USD
Liabilities 104M USD +11.3%
Common Stocks, Including Additional Paid in Capital 1.7B USD +49%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.04M USD
Retained Earnings (Accumulated Deficit) -872M USD -46.8%
Stockholders' Equity Attributable to Parent 833M USD +52.1%
Liabilities and Equity 937M USD +46.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52.9M USD -29.8%
Net Cash Provided by (Used in) Financing Activities 394M USD +81217%
Net Cash Provided by (Used in) Investing Activities 309K USD -99.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 80.8M shares +21.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 341M USD +3902%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 319M USD +121%
Deferred Tax Assets, Valuation Allowance 185M USD +46.8%
Deferred Tax Assets, Gross 195M USD +54%
Operating Lease, Liability 52.5M USD +0.71%
Payments to Acquire Property, Plant, and Equipment 1.33M USD +8225%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -275M USD -40.8%
Lessee, Operating Lease, Liability, to be Paid 81.4M USD -3.83%
Property, Plant and Equipment, Gross 18.7M USD +27.7%
Operating Lease, Liability, Current 7.41M USD +85.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.47M USD -0.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.94M USD -65.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.8M USD -11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.8M USD -0.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.95M USD +69%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7M USD -0.5%
Operating Lease, Payments 300K USD -66.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 62.2M USD +66.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%